Pde4B Protein — Phosphodiesterase 4B plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
| Phosphodiesterase 4B | |
|---|---|
| Protein Name | PDE4B (cAMP-specific phosphodiesterase) |
| Gene | PDE4B |
| Uni> | |
| PDB Structure | 1ROR, 1RO6, 5O9L |
| Molecular Weight | 70 kDa (isoform-dependent) |
| Subcellular Localization | Cytoplasm, membrane-associated |
| Protein Family | PDE4 family (Phosphodiesterase type 4) |
| EC Number | 3.1.4.53 |
Phosphodiesterase 4B (PDE4B) is a member of the phosphodiesterase type 4 family that specifically hydrolyzes cyclic adenosine monophosphate (cAMP). PDE4B is a key regulator of intracellular cAMP signaling in immune cells and neurons, making it a critical target for understanding neuroinflammatory and neurodegenerative processes. The enzyme is encoded by the PDE4B gene located on chromosome 1p31.3.
PDE4B has multiple isoforms generated by alternative splicing:
These isoforms differ in their regulatory properties and subcellular localization.
The PDE4B protein comprises:
The catalytic pocket binds cAMP with high specificity, hydrolyzing it to AMP.
PDE4B catalyzes the hydrolysis of cAMP through a two-metal ion mechanism:
This reaction terminates cAMP signaling and regulates the duration of second messenger responses.
PDE4B is highly expressed in inflammatory cells including:
In the central nervous system, PDE4B:
PDE4B participates in metabolic regulation through:
PDE4B is implicated in Alzheimer's disease pathogenesis through multiple mechanisms:
Amyloid-β toxicity: Elevated PDE4B activity exacerbates neuronal dysfunction in the presence of amyloid-β plaques. Inhibition of PDE4B protects against Aβ-induced cognitive deficits 1.
Tau pathology: PDE4B regulates tau phosphorylation through cAMP/PKA signaling pathways. Dysregulation contributes to tau hyperphosphorylation and NFT formation.
Neuroinflammation: Microglial PDE4B drives pro-inflammatory cytokine production, creating a chronic inflammatory environment that promotes neurodegeneration.
Synaptic plasticity: PDE4B activity impairs long-term potentiation (LTP) and memory consolidation. PDE4 inhibitors enhance memory in animal models.
In Parkinson's disease, PDE4B:
PDE4B dysregulation contributes to motor neuron degeneration through:
Genetic association studies have linked PDE4B polymorphisms with schizophrenia susceptibility. The protein is involved in dopaminergic and glutamatergic signaling pathways implicated in psychosis.
Clinical Approved:
In Development:
PDE4B interacts with:
Pde4B Protein — Phosphodiesterase 4B plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Pde4B Protein — Phosphodiesterase 4B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.